Professional Documents
Culture Documents
HOON CHUNG,1,2 TIANHONG DAI,1,2 SULBHA K. SHARMA,1 YING-YING HUANG,1,2,3 JAMES D. CARROLL,4
and MICHAEL R. HAMBLIN1,2,5
- Protegido
por Eduzz.com
1
Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA; 2Department of Dermatology,
Harvard Medical School, Boston, MA, USA; 3Aesthetic and Plastic Center of Guangxi Medical University, Nanning, People’s
por Eduzz.com
Republic of China; 4Thor Photomedicine Ltd, 18A East Street, Chesham HP5 1HQ, UK; and 5Harvard-MIT Division of Health
Sciences and Technology, Cambridge, MA, USA
(Received 26 July 2011; accepted 20 October 2011)
Abstract—Soon after the discovery of lasers in the 1960s it He also demonstrated that the HeNe laser could
was realized that laser therapy had the potential to improve stimulate wound healing in mice.70 Mester soon
wound healing and reduce pain, inflammation and swelling. applied his findings to human patients, using lasers to
In recent years the field sometimes known as photobiomod-
ulation has broadened to include light-emitting diodes and treat patients with nonhealing skin ulcers.69,71 LLLT
other light sources, and the range of wavelengths used now has now developed into a therapeutic procedure that is
includes many in the red and near infrared. The term ‘‘low used in three main ways: to reduce inflammation,
level laser therapy’’ or LLLT has become widely recognized edema, and chronic joint disorders9,18,40; to promote
and implies the existence of the biphasic dose response or the healing of wounds, deeper tissues, and nerves24,87; and
Arndt-Schulz curve. This review will cover the mechanisms
of action of LLLT at a cellular and at a tissular level and will to treat neurological disorders and pain.17
summarize the various light sources and principles of LLLT involves exposing cells or tissue to low levels
dosimetry that are employed in clinical practice. The range of red and near infrared (NIR) light, and is referred to
of diseases, injuries, and conditions that can be benefited by as ‘‘low level’’ because of its use of light at energy
LLLT will be summarized with an emphasis on those that densities that are low compared to other forms of laser
have reported randomized controlled clinical trials. Serious
life-threatening diseases such as stroke, heart attack, spinal therapy that are used for ablation, cutting, and ther-
cord injury, and traumatic brain injury may soon be mally coagulating tissue. LLLT is also known as ‘‘cold
amenable to LLLT therapy. laser’’ therapy as the power densities used are lower
than those needed to produce heating of tissue. It was
Keywords—Low level laser therapy, Photobiomodulation, originally believed that LLLT or photobiomodulation
Mitochondria, Tissue optics, Wound healing, Hair regrowth, required the use of coherent laser light, but more re-
Laser acupuncture. cently, light emitting diodes (LEDs) have been pro-
posed as a cheaper alternative. A great deal of debate
remains over whether the two light sources differ in
INTRODUCTION AND HISTORY their clinical effects.
Although LLLT is now used to treat a wide variety
Low level laser therapy (LLLT), also known as of ailments, it remains controversial as a therapy for
photobiomodulation, came into being in its modern two principle reasons: first, its underlying biochemical
form soon after the invention of the ruby laser in 1960, mechanisms remain poorly understood, so its use is
and the helium–neon (HeNe) laser in 1961. In 1967, largely empirical. Second, a large number of parame-
Endre Mester, working at Semmelweis University in ters such as the wavelength, fluence, power density,
Budapest, Hungary, noticed that applying laser light to pulse structure, and timing of the applied light must be
the backs of shaven mice could induce the shaved hair chosen for each treatment. A less than optimal choice
to grow back more quickly than in unshaved mice.72 of parameters can result in reduced effectiveness of the
treatment, or even a negative therapeutic outcome. As
a result, many of the published results on LLLT in-
Address correspondence to Michael R. Hamblin, Wellman Cen-
ter for Photomedicine, Massachusetts General Hospital, Boston, clude negative results simply because of an inappro-
MA, USA. Electronic mail: hamblin@helix.mgh.harvard.edu priate choice of light source and dosage. This choice is
CHUNG et al.
particularly important as there is an optimal dose of A laser is a device that emits light through a process
Roberta Chagas
light for any particular application, and doses higher of optical amplification based on the stimulated emis-
Dutra da- Silva
or lower than this optimal value may have no thera- sion of photons. The term ‘‘laser’’ originated as an
peutic effect. In fact, LLLT is characterized by a bi- acronym for light amplification by stimulated emission
phasic dose response: lower doses of light are often of radiation.65 The emitted laser light is notable for its
34924759813
more beneficial than high doses.38,85,105,108 high degree of spatial and temporal coherence.
- Protegido
FIGURE 1. Basic physics of LLLT. (a) Light as an electromagnetic wave. (b) Gaussian laser beam profile. (c) Snellius’ law of
reflection. (d) Optical window because of minimized absorption and scattering of light by the most important tissue chromophores
in the near-infrared spectral region.
Licenciado para - Paloma
referred to as the 1/e2 radius, or diameter, of the beam; energy. The scattering, similar to absorption, is ex-
Roberta Chagas
at this radial distance from the center of the beam, pressed by the scattering coefficient ls (cm21). The
irradiation is lower by a factor of 0.135 (1/e2) relative
Dutra da- Silva
Light Emitting Diodes (LED) described by the anisotropy factor g.g can have abso-
lute values from 0 to 1, from isotropic scattering
- Protegido
CHUNG et al.
has a wide range of effects at the molecular, cellular, At the most basic level, LLLT acts by inducing a
Roberta Chagas
and tissular levels. In addition, its specific modes of photochemical reaction in the cell, a process referred to
Dutra da- Silva
action may vary among different applications. Within as biostimulation or photobiomodulation. When a
the cell, there is strong evidence to suggest that LLLT photon of light is absorbed by a chromophore in the
acts on the mitochondria27 to increase adenosine tri- treated cells, an electron in the chromophore can
34924759813
phosphate (ATP) production,43 modulation of reactive become excited and jump from a low-energy orbit to a
- Protegido
oxygen species (ROS), and the induction of transcrip- higher-energy orbit.42,108 This stored energy can then
tion factors.15 Several transcription factors are regu- be used by the system to perform various cellular tasks.
- Protegido
por Eduzz.com
lated by changes in cellular redox state. Among them There are several pieces of evidence that point to a
redox factor-1 (Ref-1) dependent activator protein-1 chromophore within mitochondria being the initial
por Eduzz.com
(AP-1) (a heterodimer of c-Fos and c-Jun), nuclear target of LLLT. Radiation of tissue with light causes
factor kappa B (NF-jB), p53, activating transcription an increase in mitochondrial products such as ATP,
factor/cAMP-response element–binding protein (ATF/ NADH, protein, and RNA,83 as well as a reciprocal
CREB), hypoxia-inducible factor (HIF)-1, and HIF- augmentation in oxygen consumption, and various
like factor.15 These transcription factors then cause in vitro experiments have confirmed that cellular res-
protein synthesis that triggers further effects down- piration is upregulated when mitochondria are exposed
stream, such as increased cell proliferation and to an HeNe laser or other forms of illumination.
migration, modulation in the levels of cytokines, The relevant chromophore can be identified by
growth factors and inflammatory mediators, and matching the action spectra for the biological response
increased tissue oxygenation.45 Figure 2 shows the to light in the NIR range to the absorption spectra of
proposed cellular and molecular mechanisms of LLLT. the four membrane-bound complexes identified in
Immune cells, in particular, appear to be strongly mitochondria.42 This procedure indicates that complex
affected by LLLT. Mast cells, which play a crucial role IV, also known as cytochrome c oxidase (CCO), is the
in the movement of leukocytes, are of considerable crucial chromophore in the cellular response to
importance in inflammation. Specific wavelengths of LLLT.44 CCO is a large transmembrane protein
light are able to trigger mast cell degranulation,22 complex, consisting of two copper centers and two
which results in the release of the pro-inflammatory heme–iron centers, which is a component of the
cytokine TNF-a from the cells.115 This leads to respiratory electron transport chain.10 The electron
increased infiltration of the tissues by leukocytes. transport chain passes high-energy electrons from
LLLT also enhances the proliferation, maturation, and electron carriers through a series of transmembrane
motility of fibroblasts, and increases the production of complexes (including CCO) to the final electron
basic fibroblast growth factor.31,67 Lymphocytes acceptor, generating a proton gradient that is used to
become activated and proliferate more rapidly, and produce ATP. Thus, the application of light directly
epithelial cells become more motile, allowing wound influences ATP production by affecting one of the
sites to close more quickly. The ability of macrophages transmembrane complexes in the chain: in particular,
to act as phagocytes is also enhanced under the LLLT results in increased ATP production and elec-
application of LLLT. tron transport.47,84
FIGURE 2. Cellular mechanisms of LLLT. Schematic diagram showing the absorption of red or near infrared (NIR) light by specific
cellular chromophores or photoacceptors localized in the mitochondrial. During this process in mitochondria respiration chain
ATP production will increase, and reactive oxygen species (ROS) are generated; nitric oxide is released or generated. These
cytosolic responses may in turn induce transcriptional changes via activation of transcription factors (e.g., NF-jB and AP1).
Licenciado para - Paloma
The precise manner in which light affects CCO is activates transcription factors, which leads to the
Roberta Chagas
not yet known. The observation that NO is released upregulation of various stimulatory and protective
Dutra da- Silva
from cells during LLLT has led to speculation that genes. These genes are most likely related to cellular
CCO and NO release are linked by two possible proliferation,76 migration,32 and the production of
pathways (Fig. 3). It is possible that LLLT may cause cytokines and growth factors, which have all been
34924759813
piration is downregulated by the production of NO by The processes described above are almost certainly
mitochondrial NO synthase (mtNOS, a NOS isoform only part of the story needed to explain all the effects
- Protegido
por Eduzz.com
specific to mitochondria), that binds to CCO and of LLLT. Among its many effects, LLLT has been
inhibits it. The NO displaces oxygen from CCO, shown to cause vasodilation by triggering the relaxa-
por Eduzz.com
inhibiting cellular respiration and thus decreasing the tion of smooth muscle associated with endothelium,
production of ATP.5 By dissociating NO from CCO, which is highly relevant to the treatment of joint
LLLT prevents this process from taking place and re- inflammation. This vasodilation increases the avail-
sults in increased ATP production. An alternative or ability of oxygen to treated cells, and also allows for
parallel mechanism to explain the biological activity of greater traffic of immune cells into tissue. These two
red or NIR light to release NO from cells or tissue is effects contribute to accelerated healing. NO is a po-
the following.61,127 A new explanation has been re- tent vasodilator via its effect on cyclic guanine mono-
cently proposed for how light increases NO bioavail- phosphate production, and it has been hypothesized
ability.88 CCO can act as a nitrite reductase enzyme (a that LLLT may cause photodissociation of NO, not
one electron reduction of nitrite gives NO) particularly only from CCO, but from intracellular stores such as
when the oxygen partial pressure is low.6 Ball et al. nitrosylated forms of both hemoglobin and myoglobin,
showed 590 ± 14 nm LED light stimulated CCO/NO leading to vasodilation.61
synthesis at physiological nitrite concentrations at hy-
poxia condition.6 The following reaction may take
place: LIGHT SOURCES AND DOSIMETRY
NO"
2
þ
+ 2H + e "
ðCCOÞ ! NO + H2 O
Currently, one of the biggest sources of debate in
The influence of LLLT on the electron transport the choice of light sources for LLLT is the choice
chain extends far beyond simply increasing the levels of between lasers and LEDs. LEDs have become wide-
ATP produced by a cell. Oxygen acts as the final spread in LLLT devices. Most initial work in LLLT
electron acceptor in the electron transport chain and is, used the HeNe laser, which emits light of wavelength
in the process, converted to water. Part of the oxygen 632.8-nm, while nowadays semi-conductor diode lasers
that is metabolized produces reactive oxygen species such as gallium arsenide (GaAs) lasers have increased
(ROS) as a natural by-product. ROS are chemically in popularity. It was originally believed that the
active molecules that play an important role in cell coherence of laser light was crucial to achieve the
signaling, regulation of cell cycle progression, enzyme therapeutic effects of LLLT, but recently this notion
activation, and nucleic acid and protein synthesis. has been challenged by the use of LEDs, which emit
Because LLLT promotes the metabolism of oxygen, it non-coherent light over a wider range of wavelengths
also acts to increase ROS production. In turn, ROS than lasers. It has yet to be determined whether there is
a real difference between laser and LED, and if it in-
deed exists, whether the difference results from the
coherence or the monochromaticity of laser light, as
opposed to the non-coherence and wider bandwidth of
LED light.
A future development in LLLT devices will be the
use of organic light emitting diodes (OLEDs). These
are LEDs in which the emissive electroluminescent
layer is a film of organic compounds which emit light
in response to an electric current.122 They operate in a
similar manner to traditional semiconductor material
whereby electrons and the holes recombine forming an
exciton. The decay of this excited state results in a
FIGURE 3. Two possible sources of nitric oxide (NO) release relaxation of the energy levels of the electron, accom-
from cytochrome c oxidase (CCO). Path1 shows CCO can act
as a nitrite reductase enzyme: Path 2 shows possible photo- panied by emission of radiation whose frequency is in
dissociation of NO from CCO. the visible region.
Licenciado para - Paloma
CHUNG et al.
The wavelengths of light used for LLLT fall into an has meant that the choice of parameters has often
Roberta Chagas
‘‘optical window’’ at red and NIR wavelengths depended on the experimenter’s or the practitioner’s
Dutra da- Silva
(600–1070 nm) (Fig. 1d). Effective tissue penetration is personal preference or experience rather than on a
maximized in this range, as the principal tissue chro- consensus statement by an authoritative body. Never-
mophores (hemoglobin and melanin) have high theless, the World Association of Laser Therapy
34924759813
absorption bands at wavelengths shorter than 600 nm. (WALT) has attempted to provide dosage guidelines
- Protegido
700–770 nm have been found to have limited bio- It is well established that if the light applied is not of
chemical activity and are therefore not used. There are sufficient irradiance or the irradiation time is too short
also reports of the effectiveness of wavelengths outside then there is no response. If the irradiance is too high
the range of absorption of NIR light by CCO. These or irradiation time is too long then the response may
wavelengths are in the near IR,36 the mid-IR region be inhibited.11,33,53 Somewhere in between is the opti-
including carbon dioxide laser (10.6 lm)126 and also mal combination of irradiance and time for stimula-
include broad band IR sources in the 10–50 lm tion. This dose response often likened to the biphasic
range.39 The chromophore in these situations is almost response known as ‘‘Arndt-Schulz Law’’68,105,116 which
certainly water, possible present in biological mem- dates back to 1887 when Hugo Schulz published a
branes in some nanostructured form, that is different paper showing that various poisons at low doses have a
from bulk water allowing biological effects without stimulatory effect on yeast metabolism when given in
gross heating of the tissue.94,95 It is at present not clear low doses116 then later with Rudolph Arndt they
at which wavelength CCO absorption ceases and water developed their principle claiming that a weak stimuli
absorption commences to be important. slightly accelerates activity, stronger stimuli raise it
further, but a peak is reached and that a stronger
stimulus will suppress activity.63 A more credible term
Dosimetry
better known in other areas of science and medicine is
The power of light used typically lies in the range Hueppe’s Rule. In 1896 Ferdinand Hueppe built on
1–1000 mW, and varies widely depending on the par- Hugo Schulz’s initial findings by showing low dose
ticular application. There is evidence to suggest that stimulation/high dose inhibition of bacteria by toxic
the effectiveness of the treatment varies greatly on both agents. This is better known today by the term ‘‘hor-
the energy and power density used: there appears to be mesis’’ first coined in 1941 and first referenced in
upper and lower thresholds for both parameters 1943,63 which has subsequently been discussed multiple
between which LLLT is effective. Outside these times in LLLT research.34,38
thresholds, the light is either too weak to have any A graphical depiction of how the response to LLLT
effect, or so strong that its harmful effects outweigh its varies as a function of the combination of irradiance
benefits. (medicine) and time (dose) is shown in Fig. 4, as a 3D
Response to LLLT changes with wavelength, irra- model to represent the possible biphasic responses to
diance, time, pulses and maybe even coherence and the various combinations of irradiance and time or
polarization, the treatment should cover an adequate fluence.
area of the pathology, and then there is a matter of
how long to irradiate for.
Dosimetry is best described in two parts, SURVEY OF CONDITIONS TREATED WITH
1. Irradiation parameters (‘‘the medicine’’) see LLLT
Table 1
LLLT is used for three main purposes: to promote
2. Time/energy/fluence delivered (‘‘the dose’’) see
wound healing, tissue repair, and the prevention of
Table 2
tissue death; to relieve inflammation and edema be-
Dosimetry in LLLT is highly complicated. The large cause of injuries or chronic diseases; and as an
of number of interrelated parameters (see Table 1) has analgesic and a treatment for other neurological
meant that there has not yet been a comprehensive problems. These applications appear in a wide range of
study reported that examined the effect of varying all clinical settings, ranging from dentistry, to dermatol-
the individual parameters one by one, and it must be ogy, to rheumatology and physiotherapy. Table 3
pointed out that it is unlikely there will ever be such a summarizes some of the published studies in animal
study carried out. This considerable level of complexity models of diseases and conditions treated with LLLT.
Licenciado para - Paloma
Table 4 summarizes some of the published clinical of LLLT speculate that this result is achieved by
trials of LLLT. increasing the production and activity of fibroblasts
Wound healing was one of the first applications of and macrophages, improving the mobility of leuko-
LLLT, when HeNe lasers were used by Mester et al. to cytes, promoting collagen formation, and inducing neo-
treat skin ulcers.69–71 LLLT is believed to affect all vascularization.31,60,67,80,90,104
three phases of wound healing111: the inflammatory However, there is a lack of convincing clinical
phase, in which immune cells migrate to the wound, studies that either prove or disprove the efficacy of
the proliferative phase, which results in increased LLLT in wound healing. The results that are currently
production of fibroblasts and macrophages, and the available are conflicting and do not lead to any clear
remodeling phase, in which collagen deposition occurs conclusions. For example, Abergel et al. found that the
at the wound site and the extra-cellular matrix is re- 632.8 nm HeNe laser did not have any effect on the
built. cellular proliferation of fibroblasts, while the 904 nm
LLLT is believed to promote wound healing by GaAs laser actually lowered fibroblasts proliferation.1
inducing the local release of cytokines, chemokines, and In contrast, other studies noted an increase in prolif-
other biological response modifiers that reduce the time eration of human fibroblasts exposed to 904 nm GaAs
required for wound closure, and increase the mean lasers,85 rat myofibroblasts exposed to 670 nm GaAs
breaking strength of the wound.8,32,73 Proponents lasers,67 and gingival fibroblasts exposed to diode la-
Licenciado para - Paloma
CHUNG et al.
Roberta Chagas
Energy (Joules) J Calculated as: Power (W) 9 time (s) = Energy (Joules)
Dutra da- Silva
TABLE 3. Pre-clinical studies on animals with low level light therapy for different conditions.
Myocardial infarction 804 nm; 38 mW; 4.5 ± 0.1 mW/cm2; Rats Reduced the loss of myocardial tissue 2
0.27 J/cm2; CW, 1.5 9 3.5 mm
Myocardial infarction 635 nm, 5 mW, 6 mW/cm2; 0.8 J–1 J/cm2; Rats The expression of multiple cytokines was regulated 123
CW; 0.8 cm2; 150 s in the acute phase after LLLI
Myocardial infarction 804 nm; 400 mW 8 mW/cm2; 0.96 J/cm2; Rats and VEGF and iNOS expression markedly upregulated; 113
CW; 2 cm2; 120 s dogs angiogenesis and cardioprotection enhanced
Stroke 808-nm; .5 mW/cm2; 0.9 J/cm2 at cortical Rabbits The results showed that laser administered 6 h following 54
surface; CW; 300 ls embolic strokes in rabbits in P mode can result in
pulse at 1 kHz; 2.2 ms at 100 Hz significant clinical improvement and should be considered
for clinical development
Stroke 808-nm; 7.5 mW/cm2; 0.9 J/cm2; 3.6 J/cm2 Rats LLLT issued 24 h after acute stroke may provide a significant 81
at cortical surface; CW and 70 Hz, functional benefit with an underlying mechanism possibly
4-mm diameter being induction of neurogenesis
TBI 808 ± 10 nm; 70 mW; 2230 mW/cm2; Rats Single and multiple applications of transcranial laser therapy 64
268 J/cm2 at the scalp; 10 mW/cm2; with 808-nm CW laser light appears to be safe in
1.2 J/cm2 at cortical surface; CW; 2 mm2 Sprague–Dawley rats 1 year after treatment
TBI 808-nm; 200 mW; 10 and 20 mW/cm2; Mice LLLT given 4 h following TBI provides a significant 82
1.2–2.4 J/cm2 at cortical surface; long-term functional neurological benefit
4 h post-trauma
TBI 660 nm or 780 nm, 40 mW; 3 J/cm2 Rats LLLT affected TNF-alpha, IL-1beta, and IL-6 levels in 77
or 5 J/cm2; CW; 0.042 cm2 (3 s and 5 s) the brain and in circulation in the first 24 h following
irradiated twice (3 h interval) cryogenic brain injury
Spinal cord injury 830 nm; 100 mW; 30 mW/cm2; 250 J/cm2; Rats LLLT initiated a positive bone-tissue response, maybe 66
CW, 0.028 cm2 through stimulation of osteoblasts. However, the evoked
tissue response did not affect biomechanical or
densitometric modifications
Spinal cord injury 810 nm; 1589 J/cm2; 0.3 cm2, 2997 s; Rats Promotes axonal regeneration and functional recovery 120
daily for 14 days in acute SCI
Arthritis 632.8 nm; 5 mW; 8 J/cm2, CW; 2-mm Rats Laser reduced the intensity of the inflammatory process 92
diameter; 50 s; daily for 5 days in the arthritis model induced by hydroxyapatite and
calcium pyrophosphate crystals
The Nuts and Bolts of Low-level Laser (Light) Therapy
Arthritis 632.8-nm; 3.1 mW/cm2 CW, 1 cm diameter; Rats He–Ne laser treatment enhanced the biosynthesis 59
15 min; 3 times a week for 8 weeks of arthritic cartilage
Arthritis 810-nm; 5 or 50 mW/cm2; 3 or 30 J/cm2; Rats Highly effective in treating inflammatory arthritis. 11
CW; 4.5-cm diameter; 1, 10 or 100 min; Illumination time may be an important parameter
daily for 5 days
Wound healing 632.8-nm laser; 635, 670, 720 or 810-nm Mice 635-nm light had a maximum positive effect at 2 J/cm2. 20
(±15-nm filtered lamp); 0.59, 0.79, and 820 nm was found to be the best wavelength. No difference
0.86 mW/cm2; 1, 2, 10 and 50 J/cm2; between non-coherent 635 ± 15-nm light from a lamp and
CW; 3-cm diameter coherent 633-nm light from a He/Ne laser. LLLT increased
the number of a-smooth muscle actin (SMA)-positive cells
at the wound edge
i-
Licenciado para - Paloma
CHUNG et al.
References
The laser parameters are given in the following order: wavelength (nm); power (mW), power density (mW/cm2); energy (J); energy density (J/cm2); mode (CW) or pulsed (Hz); spot size
osteoarthritis, patellofemoral pain syndrome, and
mechanical spine disorders.9 However, the authors of
Dutra da- Silva
TABLE 4. Clinical studies on patients with low level light therapy for different conditions.
Myocardial infarction 632.8-nm, 5 mW; CW; 15 min; 39 patients An improvement of functional capacity 131
6 days a week for 4 weeks and less frequent angina symptoms
on chest skin during exercise tests
Stroke (NEST-1) 808-nm; 700 mW/cm2 on shaved 120 patients The NEST-1 study indicated that 51
scalp with cooling; 1 J/cm2 at infrared laser therapy has shown
cortical surface; 20 predetermined initial safety and effectiveness for
locations 2 min each the treatment of ischemic stroke
in humans when initiated within
24 h of stroke onset
Stroke 808-nm; 700 mW/cm2 on shaved scalp 660 patients TLT within 24 h from stroke onset demonstrated 130
(NEST-2) with cooling; 1 J/cm2 at cortical safety but did not meet formal statistical
surface; 20 predetermined significance for efficacy. However,
locations 2 min each all predefined analyses showed a favorable
trend, consistent with the previous clinical
trial (NEST-1). Both studies indicate that
mortality and adverse event rates were not
adversely affected by TLT. A definitive trial with
refined baseline National Institutes of Health
Stroke Scale exclusion criteria is planned
Chronic TBI 9 9 635 and 52 9 870-nm LED cluster; 2 patients Transcranial LED may improve cognition 79
12-15 mW per diode; 500 mW; in chronic TBI patients even years after injury
22.2 mW/cm2; 13.3 J/cm2 at scalp
(estimated 0.4 J/cm2 to cortex);
2.1¢¢ diameter
Major depression 810-nm, 250 mW/cm2; 60 J/cm2 10 patients Significant improvement in Hamilton 96
and anxiety on scalp; 2.1 J/cm2 at cortical depression and anxiety scales at 2 weeks
surface; CW; 4 cm2; 240 s at
each of 2 sites on forehead
Oral mucositis 830 nm; 150 mW; repeated every 48 h 16 patients Immediate pain relief and improved wound 12
healing resolved functional impairment
that was obtained in all cases
The Nuts and Bolts of Low-level Laser (Light) Therapy
Oral mucositis 830 nm; 15 mW; 12 J/cm2; CW; 0.2 cm2; 12 patients The prophylactic use of the treatment proposed 58
daily for 5 days commencing at start in this study seemed to reduce the incidence
of radio/chemotherapy of severe oral mucositis lesions. LLLT was
effective in delaying the appearance
of severe oral mucosistis
Oral mucositis 660-nm; 10-mW; 2.5 J/cm2, CW; 75 patients LLLT therapy was not effective in reducing severe 26
4 mm2; daily for 5 days oral mucositis, although a marginal benefit could
not be excluded. It reduced radiation therapy
interruptions in these head-and-neck cancer
patients, which might translate into
improved CRT efficacy
Licenciado para - Paloma
Roberta Chagas 34924759813
Dutra da- Silva - Protegido
- Protegido
por Eduzz.com
por Eduzz.com
TABLE 4. continued.
Carpal tunnel 830-nm; 60 mW; 9.7 J/cm2; 10 Hz, 75 patients Alleviate pain and symptoms, improve functional 14
syndrome (CTS) 50% duty cycle, 10-min per day ability and finger and hand strength
for 5 days a week for mild and moderate CTS patients
Carpal tunnel 632.8-nm; 9–11 J/cm2; CW; 80 patients Effective in treating CTS paresthesia and numbness 102
syndrome (CTS) 5 times/week for 3 weeks and improved the subjects’ power of hand-grip
and electrophysiological parameters
Carpal tunnel 830-nm; 50 mW; 1.2 J/point; CW; 60 patients LLLT was no more effective than placebo in CTS 110
syndrome (CTS) 1 mm diameter. 2 min/point; 5 points across
the median nerve trace; 5 times per
week for 3 weeks
Lateral epicondylitis (LE) 905 nm; 100 mW; 1 J/cm2; 1000 Hz; 49 patients No advantage for the short term; significant 23
2 min; 5 days per week for 3 weeks improvement in functional parameters
in the long term
Lateral epicondylitis (LE) 904-nm; 25 mW, 0.275 J/point; 2.4 J/cm2; 39 patients LLLT in addition to exercise is effective in 50
pulse duration 200 nsec; 5000 Hz; relieving pain, and in improving the grip
4-mm diameter 11 s/point; 3 times/week strength and subjective rating of physical
for 3 weeks function of patients with lateral epicondylitis
Lateral epicondylitis (LE) 830 nm; 120 mW; CW; 5-mm diameter; 324 patients It was observed that under- and overirradiation can 103
632.8 nm, 10 mW, CW; 2-mm diameter; result in the absence of positive therapy effects
904 nm, 10 mW; pulsed; 2.5–4 J/point; or even opposite, negative (e.g., inhibitory) effects.
12 J/cm2; 3–5 times/week for 2–5 weeks The current clinical study provides further evidence
of the efficacy of LLLT in the management
of lateral and medial epicondylitis
CHUNG et al.
Arthritis 830 nm, 50 mW; 10 W/cm2; 6 J/point; 27 patients Reduces pain in knee osteoarthritis and 35
48 J/cm2; CW, 0.5-mm2; 2 times/week improves microcirculation
for 4 weeks
Arthritis 904-nm; 10 mW; 3 J/point; 3 J/cm2; 90 patients The study demonstrated that applications 28
200 nsec; 2500 Hz; 1 cm2; 2 points of LLLT in regardless of dose and duration
5 times/week for 2 weeks were a safe and effective method in
treatment of knee osteoarthritis
Leg ulcers 685 nm; 50 mW; 50 mW/cm2; 10 J/cm2; 23 patients The study provided evidence that LLLT can 48
CW; 1 cm2; 200 s; 6 times per week, accelerate the healing process of chronic
for 2 weeks then every 2 days diabetic foot ulcers, and it can be presumed
that LLLT may shorten the time period
needed to achieve complete healing
Leg ulcers 685-nm; 200 mW; 4 J/cm2 44 patients No statistically significant differences 49
in reduction of wound size
a
The light sources were all lasers unless LED is specifically mentioned.
b
The laser parameters are given in the following order: wavelength (nm); power (mW), power density (mW/cm2); energy (J); energy density (J/cm2); mode (CW) or pulsed (Hz); spot size
(cm2); illumination time (sec); treatment repetition. In many cases, the parameters are partially unavailable.
Licenciado para - Paloma
4 weeks to manifest, reflecting the time necessary for therapeutic effect will be circulated through the
Roberta Chagas
new neurons to form and gather at the damaged site circulatory system117 (see Fig. 5b). The feasibility of
in the brain.21,101 However, the exact processes
Dutra da- Silva
LLLT has also been considered as a candidate for primarily in Asia (including Russia) and is not exten-
- Protegido
treating degenerative brain disorders such as familial sively used in other parts of the world. It is claimed to
amyotropic lateral sclerosis (FALS), Alzheimer’s dis- improve blood flow and its transport activities, but has
- Protegido
por Eduzz.com
ease, and Parkinson’s disease (PD).75,129 Although not been subject to randomized controlled trials and is
only preliminary studies have been carried out, there subject to skepticism. Although it is at present uncer-
por Eduzz.com
are encouraging indications that merit further investi- tain what the mechanisms of intravascular laser actu-
gation. Michalikova et al. found that LLLT could ally are, and why it differs from traditional laser
reverse memory degradation and induce improved therapy; it has been hypothesized to affect particular
cognitive performance in middle-aged mice,74 and components of the blood. Blood lipids (low density
Trimmer et al. found that motor function was signifi- lipoprotein, high density lipoprotein, and cholesterol)
cantly improved in human patients treated with LLLT are said to be ‘‘normalized’’56; platelets are thought to
in an early stage of FALS.112 be rendered less likely to aggregate thus lessening the
likelihood of clot formation,107 and the immune system
(dendritic cells, macrophages and lymphocytes) may be
Intravascular Laser Therapy
activated.109
Intravenous or intravascular blood irradiation
involves the in vivo illumination of the blood by feeding
Laser Acupuncture and Trigger Points
low level laser light generated by a 1–3 mW low power
laser at a variety of wavelengths through a fiber optic Low power lasers with small focused spots can be
inserted in a vascular channel, usually a vein in the used to stimulate acupuncture points using the same
forearm (Fig. 5a), under the assumption that any rules of point selection as in traditional Chinese needle
FIGURE 5. Some examples of LLLT devices and applications. (a and b) Intravascular laser therapy (Institute of Biological Laser
therapy, Gottingen, Germany). (c and d) Laserneedle acupuncture system (Laserneedle GmbH, Glienicke-Nordbahn, Germany). (e
and f) Lasercomb (Lexington Int LLC, Boca Raton, FL) for hair regrowth. (g) Laser cap (Transdermal Cap Inc, Gates Mills, OH) for
hair regrowth.
Licenciado para - Paloma
CHUNG et al.
acupuncture.119 Laser acupuncture may be used solely We believe that LLLT will steadily progress to be
Roberta Chagas
or in combination with needles for any given condition better accepted by both the medical profession and the
Dutra da- Silva
over a course of treatment. Trigger points are defined general public at large. The number of published
as hyperirritable spots in skeletal muscle that are negative reports will continue to decline as the opti-
associated with palpable nodules in taut bands of mum LLLT parameters become better understood,
34924759813
muscle fibers. They may also be found in ligaments, and as reviewers and editors of journals become aware
- Protegido
tendons, and periosteum. Higher doses of LLLT may of LLLT as a scientifically based therapy. On the
be used for the deactivation of trigger points. Direct clinical side, the public’s distrust of big pharmaceutical
- Protegido
por Eduzz.com
irradiation over tendons, joint margins, bursae etc. companies and their products is also likely to continue
may be effective in the treatment of conditions in to grow. This may be a powerful force for adoption of
por Eduzz.com
which trigger points may play a part. The Laserneedle therapies that once were considered as ‘‘alternative and
system (see Figs. 5c, 5d) can be used to stimulate complementary,’’ but now are becoming more scien-
multiple acupuncture points or trigger points simulta- tifically accepted. LLLT is not the only example of this
neously.97 type of therapy, but needle acupuncture, transcranial
magnetic stimulation and microcurrent therapy also
fall into this class. The day may not be far off when
LLLT for Hair Regrowth
most homes will have a light source (most likely a LED
One of the most commercially successful applica- device) to be used for aches, pains, cuts, bruises, joints,
tions of LLLT is the stimulation of hair regrowth in and which can also be applied to the hair and even
balding individuals. The photobiomodulation activity transcranially to the brain.
of LLLT can cause more hair follicles to move from
telogen phase into anagen phase. The newly formed
hair is thicker and also more pigmented. The Hairmax
Lasercomb (Fig. 5e) was shown55 to give a statistically ACKNOWLEDGMENTS
significant improvement in hair growth in a random-
Funding: Research in the Hamblin laboratory is
ized, double-blind, sham device-controlled, multicenter
supported by NIH grant R01AI050875, Center for
trial in 110 men with androgenetic alopecia and this led
Integration of Medicine and Innovative Technology
to FDA clearance for efficacy (FDA 510(k) number
(DAMD17-02-2-0006), CDMRP Program in TBI
K060305).The teeth of the comb are supposed to im-
(W81XWH-09-1-0514) and Air Force Office of Scien-
prove the penetration of light though the existing hair
tific Research (FA9950-04-1-0079). Tianhong Dai
to the follicles requiring stimulation (Fig. 5f). Re-
was supported by an Airlift Research Foundation
cently, a different LLLT device received FDA clear-
Extremity Trauma Research Grant (grant 109421).
ance in women suffering from androgenetic alopecia
(FDA 510(k) numberK091496). This group of patients
have fewer treatment options than men. In order to
CONFLICTS OF INTEREST
make the application of light to the head more user-
friendly and increase patient compliance, companies James D. Carroll is the owner of THOR Photo-
have developed ‘‘laser caps’’ (Fig. 5g). medicine, a company which sells LLLT devices.
anism and biology of cytochrome oxidase inhibition by rats following acute stroke. Lasers Surg. Med. 38:70–73,
nitric oxide. Proc. Natl Acad. Sci. USA. 101:16774–16779, 2006.
34924759813
22
2004. el Sayed, S. O., and M. Dyson. Effect of laser pulse rep-
6
Ball, K. A., P. R. Castello, and R. O. Poyton. Low etition rate and pulse duration on mast cell number and
- Protegido
intensity light stimulates nitrite-dependent nitric oxide degranulation. Lasers Surg. Med. 19:433–437, 1996.
23
synthesis but not oxygen consumption by cytochrome c Emanet, S. K., L. I. Altan, and M. Yurtkuran. Investi-
- Protegido
oxidase: Implications for phototherapy. J. Photochem. gation of the effect of GaAs laser therapy on lateral epi-
por Eduzz.com
intensity laser radiation on healing of open skin wounds therapy for enhancing peripheral nerve repair: a review of
in rats. Indian J. Med. Res. 100:43–46, 1994. the literature. Muscle Nerve. 31:694–701, 2005.
8 25
Bisht, D., R. Mehrortra, P. A. Singh, S. C. Atri, and Goodson, W. H., and T. K. Hunt. Wound healing and the
A. Kumar. Effect of helium-neon laser on wound healing. diabetic patient. Surg. Gynecol. Obstet. 149:600–608, 1979.
26
Indian J. Exp. Biol. 37:187–189, 1999. Gouvea de Lima, A., R. C. Villar, G. de Castro, Jr., R.
9
Bjordal, J. M., C. Couppe, R. T. Chow, J. Tuner, and Antequera, E. Gil, M. C. Rosalmeida, M. H. Federico,
E. A. Ljunggren. A systematic review of low level laser and I. M. Snitcovsky. Oral mucositis prevention by low-
therapy with location-specific doses for pain from chronic level laser therapy in head-and-neck cancer patients
joint disorders. Aust. J. Physiother. 49:107–116, 2003. undergoing concurrent chemoradiotherapy: a phase III
10
Capaldi, R. A., F. Malatesta, and V. M. Darley-Usmar. randomized study. Int. J. Radiat. Oncol. Biol. Phys. 2010.
Structure of cytochrome c oxidase. Biochim. Biophys. Acta [Epub ahead of print]. doi:10.1016/j.ijrobp.2010.10.012.
27
726:135–148, 1983. Greco, M., G. Guida, E. Perlino, E. Marra, and
11
Castano, A. P., T. Dai, I. Yaroslavsky, R. Cohen, W. A. E. Quagliariello. Increase in RNA and protein synthesis
Apruzzese, M. H. Smotrich, and M. R. Hamblin. Low- by mitochondria irradiated with helium-neon laser. Bio-
level laser therapy for zymosan-induced arthritis in rats: chem. Biophys. Res. Commun. 163:1428–1434, 1989.
28
importance of illumination time. Lasers Surg. Med. Gur, A., A. Cosut, A. J. Sarac, R. Cevik, K. Nas, and
39:543–550, 2007. A. Uyar. Efficacy of different therapy regimes of low-
12
Cauwels, R. G., and L. C. Martens. Low level laser power laser in painful osteoarthritis of the knee: a double-
therapy in oral mucositis: a pilot study. Eur. Arch Paedi- blind and randomized-controlled trial. Lasers Surg. Med.
atr. Dent. 12:118–123, 2011. 33:330–338, 2003.
13 29
Chandrasekhar, S. Radiative transfer. New York: Dover Hashmi, J. T., Y.-Y. Huang, B. Z. Osmani, S. K. Sharma,
Publications, 1960. M. A. Naeser, and M. R. Hamblin. Role of low-level laser
14
Chang, W. D., J. H. Wu, J. A. Jiang, C. Y. Yeh, and C. T. therapy in neurorehabilitation. PM & R. 2:S292–S305,
Tsai. Carpal tunnel syndrome treated with a diode laser: a 2010.
30
controlled treatment of the transverse carpal ligament. Hashmi, J. T., Y. Y. Huang, S. K. Sharma, D. B. Kurup,
Photomed. Laser Surg. 26:551–557, 2008. L. De Taboada, J. D. Carroll, and M. R. Hamblin. Effect
15
Chen, A. C.-H., P. R. Arany, Y.-Y. Huang, E. M. Tom- of pulsing in low-level light therapy. Lasers Surg. Med.
kinson, T. Saleem, F. E. Yull, T. S. Blackwell, and M. R. 42:450–466, 2010.
31
Hamblin. Low level laser therapy activates NF-jB via Hawkins, D., and H. Abrahamse. Biological effects of
generation of reactive oxygen species in mouse embryonic helium-neon laser irradiation on normal and wounded
fibroblasts. Proc. SPIE. 7165:71650–71659, 2009. human skin fibroblasts. Photomed. Laser Surg. 23:251–
16
Cheong, W. F., S. A. Prahl, and A. J. Welch. A review of 259, 2005.
32
the optical properties of biological tissues. IEEE J. Hawkins, D., N. Houreld, and H. Abrahamse. Low level
Quantum Electron. 26:2166–2185, 1990. laser therapy (LLLT) as an effective therapeutic modality
17
Chow, R. T., M. I. Johnson, R. A. Lopes-Martins, and J. for delayed wound healing. Ann. NY Acad. Sci. 1056:486–
M. Bjordal. Efficacy of low-level laser therapy in the 493, 2005.
33
management of neck pain: a systematic review and meta- Haxsen, V., D. Schikora, U. Sommer, A. Remppis,
analysis of randomised placebo or active-treatment con- J. Greten, and C. Kasperk. Relevance of laser irradiance
trolled trials. Lancet 374:1897–1908, 2009. threshold in the induction of alkaline phosphatase in
18
Christie, A., G. Jamtvedt, K. T. Dahm, R. H. Moe, human osteoblast cultures. Lasers Med. Sci. 23:381–384,
E. Haavardsholm, and K. B. Hagen. Effectiveness of 2008.
34
nonpharmacological and nonsurgical interventions for Hayworth, C. R., J. C. Rojas, E. Padilla, G. M. Holmes,
patients with rheumatoid arthritis: an overview of sys- E. C. Sheridan, and F. Gonzalez-Lima. In vivo low-level
tematic reviews. Phys. Ther. 87:1697–1715, 2007. light therapy increases cytochrome oxidase in skeletal
19
da Silva, D. F., B. C. Vidal, D. M. Zezell, T. M. Zorn, S. muscle. Photochem. Photobiol. 86:673–680, 2010.
35
C. Nunez, and M. S. Ribeiro. Collagen birefringence in Hegedus, B., L. Viharos, M. Gervain, and M. Galfi. The
skin repair in response to red polarized-laser therapy. J. effect of low-level laser in knee osteoarthritis: a double-
Biomed. Opt. 11:024002, 2006. blind, randomized, placebo-controlled trial. Photomed.
20
Demidova-Rice, T. N., E. V. Salomatina, A. N. Yaro- Laser Surg. 27:577–584, 2009.
36
slavsky, I. M. Herman, and M. R. Hamblin. Low-level Hoffmann, G. Principles and working mechanisms of
light stimulates excisional wound healing in mice. Lasers water-filtered infrared-A (wIRA) in relation to wound
Surg. Med. 39:706–715, 2007. healing. GMS Krankenhhyg Interdiszip. 2:Doc54, 2007.
Licenciado para - Paloma
CHUNG et al.
37 54
Huang, Y.-Y., A. C.-H. Chen, J. D. Carroll, et al. Bi- Lapchak, P. A., K. F. Salgado, C. H. Chao, and J. A.
Roberta Chagas
phasic dose response in low level light therapy. Dose Re- Zivin. Transcranial near-infrared light therapy improves
sponse 7:358–383, 2009. motor function following embolic strokes in rabbits: an
Dutra da- Silva
38
Huang, Y. Y., S. K. Sharma, J. D. Carroll, and M. R. extended therapeutic window study using continuous and
Hamblin. Biphasic dose response in low level light ther- pulse frequency delivery modes. Neuroscience 148:907–
34924759813
Phantom limb pain treated by far infrared ray. Conf. Proc. HairMax LaserComb laser phototherapy device in the
IEEE Eng. Med. Biol. Soc. 2009:1589–1591, 2009. treatment of male androgenetic alopecia: a randomized,
- Protegido
40
Jamtvedt, G., K. T. Dahm, A. Christie, R. H. Moe, E. double-blind, sham device-controlled, multicentre trial.
por Eduzz.com
Haavardsholm, I. Holm, and K. B. Hagen. Physical Clin. Drug Invest. 29:283–292, 2009.
56
therapy interventions for patients with osteoarthritis of Lebed’kov, E. V., P. I. Tolstykh, L. F. Marchenko, T. I.
por Eduzz.com
the knee: an overview of systematic reviews. Phys. Ther. Turkina, and V. T. Krivikhin. The effect of the laser
88:123–136, 2008. irradiation of the blood on its lipid and phospholipid
41
Kana, J. S., G. Hutschenreiter, D. Haina, and W. Wa- components in diabetes mellitus. Voen Med. Zh. 319:37–
idelich. Effect of low-power density laser radiation on 38, 95, 1998.
57
healing of open skin wounds in rats. Arch. Surg. 116:293– Lee, G., R. M. Ikeda, R. M. Dwyer, H. Hussein, P.
296, 1981. Dietrich, and D. T. Mason. Feasibility of intravascular
42
Karu, T. I. Photobiological fundamentals of low-power laser irradiation for in vivo visualization and therapy of
laser therapy. IEEE J. Quantum Electron. 23:1703–1717, cardiocirculatory diseases. Am. Heart J. 103:1076–1077,
1987. 1982.
43 58
Karu, T. I. Primary and secondary mechanisms of action Lima, A. G., R. Antequera, M. P. Peres, I. M. Snitcosky,
of visible to near-IR radiation on cells. J. Photochem. M. H. Federico, and R. C. Villar. Efficacy of low-level
Photobiol. B. 49:1–17, 1999. laser therapy and aluminum hydroxide in patients with
44
Karu, T. I., and N. I. Afanas’eva. Cytochrome c oxidase chemotherapy and radiotherapy-induced oral mucositis.
as the primary photoacceptor upon laser exposure of Braz Dent J. 21:186–192, 2010.
59
cultured cells to visible and near IR-range light. Dokl. Lin, Y. S., M. H. Huang, and C. Y. Chai. Effects of he-
Akad. Nauk. 342:693–695, 1995. lium-neon laser on the mucopolysaccharide induction in
45
Karu, T. I., and S. F. Kolyakov. Exact action spectra for experimental osteoarthritic cartilage. Osteoarthr. Cartil.
cellular responses relevant to phototherapy. Photomed. 14:377–383, 2006.
60
Laser Surg. 23:355–361, 2005. Loevschall, H., and D. Arenholt-Bindeslev. Effect of low
46
Karu, T. I., L. V. Pyatibrat, and N. I. Afanasyeva. Cel- level diode laser irradiation of human oral mucosa fibro-
lular effects of low power laser therapy can be mediated blasts in vitro. Lasers Surg. Med. 14:347–354, 1994.
61
by nitric oxide. Lasers Surg. Med. 36:307–314, 2005. Lohr, N. L., A. Keszler, P. Pratt, M. Bienengraber, D. C.
47
Karu, T. I., L. V. Pyatibrat, and G. S. Kalendo. Irradia- Warltier, and N. Hogg. Enhancement of nitric oxide re-
tion with He-Ne laser increases ATP level in cells culti- lease from nitrosyl hemoglobin and nitrosyl myoglobin by
vated in vitro. J. Photochem. Photobiol. B 27:219–223, red/near infrared radiation: potential role in cardiopro-
1995. tection. J. Mol. Cell. Cardiol. 47:256–263, 2009.
48 62
Kaviani, A., G. E. Djavid, L. Ataie-Fashtami, M. Fateh, Lundeberg, T., and M. Malm. Low-power HeNe laser
M. Ghodsi, M. Salami, N. Zand, N. Kashef, and B. treatment of venous leg ulcers. Ann. Plast. Surg. 27:537–
Larijani. A randomized clinical trial on the effect of low- 539, 1991.
63
level laser therapy on chronic diabetic foot wound healing: Martius, F. Das Amdt-Schulz Grandgesetz. Munch. Med.
a preliminary report. Photomed. Laser Surg. 29:109–114, Wschr. 70:1005–1006, 1923.
64
2011. McCarthy, T. J., L. De Taboada, P. K. Hildebrandt, E. L.
49
Kokol, R., C. Berger, J. Haas, and D. Kopera. Venous leg Ziemer, S. P. Richieri, and J. Streeter. Long-term safety of
ulcers: no improvement of wound healing with 685-nm single and multiple infrared transcranial laser treatments
low level laser therapy. Randomised, placebo-controlled, in Sprague-Dawley rats. Photomed. Laser Surg. 28:663–
double-blind study. Hautarzt 56:570–575, 2005. 667, 2010.
50 65
Lam, L. K., and G. L. Cheing. Effects of 904-nm low-level McGuff, P. E., D. Bushnell, H. S. Soroff, and R. A. De-
laser therapy in the management of lateral epicondylitis: a terling, Jr. Studies of the surgical applications of laser
randomized controlled trial. Photomed. Laser Surg. 25:65– (light amplification by stimulated emission of radiation).
71, 2007. Surg. Forum. 14:143–145, 1963.
51 66
Lampl, Y., J. A. Zivin, M. Fisher, R. Lew, L. Welin, B. Medalha, C. C., B. O. Amorim, J. M. Ferreira, P. Oli-
Dahlof, P. Borenstein, B. Andersson, J. Perez, C. Caparo, veira, R. M. Pereira, C. Tim, A. P. Lirani-Galvao, O. L.
S. Ilic, and U. Oron. Infrared laser therapy for ischemic da Silva, and A. C. Renno. Comparison of the effects of
stroke: a new treatment strategy: results of the Neuro- electrical field stimulation and low-level laser therapy on
Thera Effectiveness and Safety Trial-1 (NEST-1). Stroke bone loss in spinal cord-injured rats. Photomed. Laser
38:1843–1849, 2007. Surg. 28:669–674, 2010.
52 67
Lane, N. Cell biology: power games. Nature 443:901–903, Medrado, A. R., L. S. Pugliese, S. R. Reis, and Z. A.
2006. Andrade. Influence of low level laser therapy on wound
53
Lanzafame, R. J., I. Stadler, A. F. Kurtz, R. Connelly, T. healing and its biological action upon myofibroblasts.
A. Peter, Sr., P. Brondon, and D. Olson. Reciprocity of Lasers Surg. Med. 32:239–244, 2003.
68
exposure time and irradiance on energy density during Mester, E., A. F. Mester, and A. Mester. The biomedical
photoradiation on wound healing in a murine pressure effects of laser application. Lasers Surg. Med. 5:31–39,
ulcer model. Lasers Surg. Med. 39:534–542, 2007. 1985.
Licenciado para - Paloma
Laser stimulation of wound healing. Acta Chir. Acad. Sci. Marques. Effect of low-power laser irradiation on cell
Hung. 17:49–55, 1976. growth and procollagen synthesis of cultured fibroblasts.
Dutra da- Silva
70
Mester, E., T. Spiry, B. Szende, and J. G. Tota. Effect of Lasers Surg. Med. 31:263–267, 2002.
86
laser rays on wound healing. Am. J. Surg. 122:532–535, Pinheiro, A. L., D. H. Pozza, M. G. Oliveira, R. Weiss-
34924759813
of wound healing by laser rays. Acta Chir. Acad. Sci. wound healing process using immunohistochemical anal-
Hung. 13:315–324, 1972. ysis. Photomed. Laser Surg. 23:485–492, 2005.
- Protegido
72 87
Mester, E., B. Szende, and J. G. Tota. Effect of laser on Posten, W., D. A. Wrone, J. S. Dover, K. A. Arndt, S.
por Eduzz.com
hair growth of mice. Kiserl Orvostud. 19:628–631, 1967. Silapunt, and M. Alam. Low-level laser therapy for
73
Meyers, A. D. Lasers and wound healing. Arch. Otolar- wound healing: mechanism and efficiency. Dermatol.
por Eduzz.com
CHUNG et al.
118
skin circulation in patients with diabetic microangiopathy. Welch, A. J., J. H. Torres, and W. F. Cheong. Laser
Roberta Chagas
Diabetes Care. 21:580–584, 1998. physics and laser-tissue interaction. Tex. Heart Inst. J.
101
Shen, J., L. Xie, X. O. Mao, Y. Zhou, R. Zhan, D. A. 16:141–149, 1989.
Dutra da- Silva
119
Greenberg, and K. Jin. Neurogenesis after primary intra- Whittaker, P. Laser acupuncture: past, present, and fu-
cerebral hemorrhage in adult human brain. J. Cereb. ture. Lasers Med. Sci. 19:69–80, 2004.
34924759813
120
Blood Flow Metab. 28:1460–1468, 2008. Wu, X., A. E. Dmitriev, M. J. Cardoso, A. G. Viers-
102
Shooshtari, S. M., V. Badiee, S. H. Taghizadeh, A. H. Costello, R. C. Borke, J. Streeter, and J. J. Anders.
- Protegido
Nematollahi, A. H. Amanollahi, and M. T. Grami. The 810 nm wavelength light: an effective therapy for tran-
effects of low level laser in clinical outcome and neuro- sected or contused rat spinal cord. Lasers Surg. Med.
- Protegido
121
myogr. Clin. Neurophysiol. 48:229–231, 2008. Wu, Q., Y. Y. Huang, S. Dhital, S. K. Sharma, A. C.
103
Simunovic, Z., T. Trobonjaca, and Z. Trobonjaca. Chen, M. J. Whalen, and M. R. Hamblin. Low level laser
por Eduzz.com
Treatment of medial and lateral epicondylitis–tennis and therapy for traumatic brain injury. Proc. SPIE.
golfer’s elbow—with low level laser therapy: a multicenter 7552:755201–755206, 2010.
122
double blind, placebo-controlled clinical study on 324 Xiao, L., Z. Chen, B. Qu, J. Luo, S. Kong, Q. Gong, and
patients. J. Clin. Laser Med. Surg. 16:145–151, 1998. J. Kido. Recent progresses on materials for electrophos-
104
Skinner, S. M., J. P. Gage, P. A. Wilce, and R. M. Shaw. A phorescent organic light-emitting devices. Adv. Mater.
preliminary study of the effects of laser radiation on collagen 23:926–952, 2011.
123
metabolism in cell culture. Aust. Dent. J. 41:188–192, 1996. Yang, Z., Y. Wu, H. Zhang, P. Jin, W. Wang, J. Hou, Y.
105
Sommer, A. P., A. L. Pinheiro, A. R. Mester, R. P. Franke, Wei, and S. Hu. Low-level laser irradiation alters cardiac
and H. T. Whelan. Biostimulatory windows in low-intensity cytokine expression following acute myocardial infarction:
laser activation: lasers, scanners, and NASA’s light-emitting a potential mechanism for laser therapy. Photomed. Laser
diode array system. J. Clin. Laser Med. Surg. 19:29–33, 2001. Surg. 29:391–398, 2011.
106 124
Spanheimer, R. G., G. E. Umpierrez, and V. Stumpf. Yu, W., J. O. Naim, and J. Lanzafame. Effects of phot-
Decreased collagen production in diabetic rats. Diabetes ostimulation on wound healing in diabetic mice. Lasers
37:371–376, 1988. Surg. Med. 20:56–63, 1997.
107 125
Stebliukova, I. A., N. B. Khairetdinova, A. M. Belov, and Yu, H. S., C. S. Wu, C. L. Yu, Y. H. Kao, and M. H.
N. A. Kakitelashvili. Effects of low-energy laser irradia- Chiou. Helium-neon laser irradiation stimulates migration
tion on platelet aggregation in cerebrovascular disorders. and proliferation in melanocytes and induces repigmen-
Sov. Med. (3):77–80, 1989. tation in segmental-type vitiligo. J. Invest. Dermatol.
108
Sutherland, J. C. Biological effects of polychromatic light. 120:56–64, 2003.
126
Photochem. Photobiol. 76:164–170, 2002. Zand, N., L. Ataie-Fashtami, G. E. Djavid, M. Fateh, M.
109
Tadakuma, T. Possible application of the laser in R. Alinaghizadeh, S. M. Fatemi, and F. Arbabi-Kalati.
immunobiology. Keio J. Med. 42:180–182, 1993. Relieving pain in minor aphthous stomatitis by a single
110
Tascioglu, F., N. A. Degirmenci, S. Ozkan, and O. Meh- session of non-thermal carbon dioxide laser irradiation.
metoglu. Low-level laser in the treatment of carpal tunnel Lasers Med. Sci. 24:515–520, 2009.
127
syndrome: clinical, electrophysiological, and ultrasono- Zhang, R., Y. Mio, P. F. Pratt, N. Lohr, D. C. Warltier,
graphical evaluation. Rheumatol. Int. 2010. [Epub ahead H. T. Whelan, D. Zhu, E. R. Jacobs, M. Medhora, and M.
of print]. doi:10.1007/s00296-010-1652-6. Bienengraeber. Near infrared light protects cardiomyo-
111
Thomas, D. W., I. D. O’Neill, K. G. Harding, and J. P. cytes from hypoxia and reoxygenation injury by a nitric
Shepherd. Cutaneous wound healing: a current perspec- oxide dependent mechanism. J. Mol. Cell. Cardiol. 46:4–
tive. J. Oral Maxillofac. Surg. 53:442–447, 1995. 14, 2009.
112 128
Trimmer, P. A., K. M. Schwartz, M. K. Borland, Zhang, Y., S. Song, C. C. Fong, C. H. CTsang, Z.
L. DeTaboada, J. Streeter, and U. Oron. Reduced axonal Yang, and M. Yang. cDNA microarray analysis of
transport in Parkinson’s disease cybrid neurites is restored gene expression profiles in human fibroblast cells irra-
by light therapy. Mol. Neurodegener. 4:26, 2009. diated with red light. J. Invest. Dermatol. 120:849–857,
113
Tuby, H., L. Maltz, and U. Oron. Modulations of VEGF 2003.
129
and iNOS in the rat heart by low level laser therapy are Zhang, L., D. Xing, D. Zhu, and Q. Chen. Low-power
associated with cardioprotection and enhanced angiogen- laser irradiation inhibiting Abeta25–35-induced PC12 cell
esis. Lasers Surg. Med. 38:682–688, 2006. apoptosis via PKC activation. Cell Physiol. Biochem.
114
Wahl, G., and S. Bastanier. Soft laser in postoperative 22:215–222, 2008.
130
care in dentoalveolar treatment. ZWR 100:512–515, 1991. Zivin, J. A., G. W. Albers, N. Bornstein, T. Chippendale,
115
Walsh, L. J., G. Trinchieri, H. A. Waldorf, D. Whitaker, B. Dahlof, T. Devlin, M. Fisher, W. Hacke, W. Holt, S.
and G. F. Murphy. Human dermal mast cells contain and Ilic, S. Kasner, R. Lew, M. Nash, J. Perez, M. Rymer, P.
release tumor necrosis factor-alpha which induces endo- Schellinger, D. Schneider, S. Schwab, R. Veltkamp, M.
thelial leukocyte adhesion molecule-1. Proc. Natl Acad. Walker, and J. Streeter. Effectiveness and safety of
Sci. USA. 88:4220–4224, 1991. transcranial laser therapy for acute ischemic stroke. Stroke
116
Webb, C., M. Dyson, and W. H. Lewis. Stimulatory effect 40:1359–1364, 2009.
131
of 660 nm low level laser energy on hypertrophic scar-- Zycinski, P., M. Krzeminska-Pakula, C. Peszynski-Drews,
derived fibroblasts: possible mechanisms for increase in A. Kierus, E. Trzos, T. Rechcinski, L. Figiel, M. Kurpesa,
cell counts. Lasers Surg. Med. 22:294–301, 1998. M. Plewka, L. Chrzanowski, and J. Drozdz. Laser bi-
117
Weber, M. H., and T. W. Fussgänger-May. Intravenous ostimulation in end-stage multivessel coronary artery dis-
laser blood irradiation. German J. Acupunct. Rel. Tech. ease–a preliminary observational study. Kardiol. Pol.
50:12–23, 2007. 65:13–21, 2007; discussion 22–13.